509 results
Page 13 of 26
8-K
EX-99.1
j4ftz7gmk7tq6 ie1
8 Aug 11
Ligand Pharmaceuticals Announces Second Quarter Results
12:00am
8-K
EX-99.1
bfmdnjbf gml06852l
26 Jul 11
Ligand Partner GlaxoSmithKline Receives Positive Data from Promacta® PIII
12:00am
8-K
EX-99.1
gqgg4y3 hd
22 Jun 11
Product has Potential to Offer Important Advantages Over Current IV Melphalan
12:00am
8-K
EX-99.1
mnf zz8svawl20
20 Jun 11
Rob McKay, Sr. Dir. Business Development
12:00am
8-K
EX-99.1
wex43xcbdfsrf5
10 May 11
Ligand Pharmaceuticals Reports First Quarter Results
12:00am
8-K
EX-99.1
jpppw0
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K/A
EX-99.2
37regcv2h h8rp6
12 Apr 11
Financial Statements and Report of Independent Certified Public Accountants
12:00am
8-K/A
EX-99.2
qi3ua
11 Apr 11
Financial Statements and Report of Independent Certified Public Accountants
12:00am
8-K
EX-10.1
agfr6
4 Apr 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
j6ax54vp0dr1r02r5
15 Feb 11
Ligand Announces Fourth Quarter and Full Year 2010 Consolidated Financial Results
12:00am
8-K
EX-99.1
bii8ua694jhqqk5wutk
9 Feb 11
Ligand Appoints John L. LaMattina to Board of Directors
12:00am
8-K
EX-99.1
sfzfy
31 Jan 11
Ligand Forms Strategic Drug Development Alliance with Chiva Pharmaceuticals
12:00am
8-K
EX-10.3
ogsr15
26 Jan 11
Entry into a Material Definitive Agreement
12:00am